Singapore markets open in 6 hours 40 minutes

Straits Times Index
3,303.66
+12.96(+0.39%)
S&P 500
5,220.59
-2.09(-0.04%)
Dow
39,450.02
-62.82(-0.16%)
Nasdaq
16,383.73
+42.87(+0.26%)
Bitcoin USD
62,742.89
+1,238.97(+2.01%)
CMC Crypto 200
1,291.16
+30.96(+2.46%)

BioMarin Pharmaceutical Inc. (0HNC.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

80.53

-0.55

(-0.68%)

At close: 06:31PM BST

Loading interactive chart…

PR Newswire
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President, and Chief Executive Officer of BioMarin will present at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 10:00am PT / 1:00pm ET, in Las Vegas, Nevada.
Zacks
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
GuruFocus.com
Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ...
On May 2, 2024, Jeffrey Ajer, the Executive Vice President and Chief Commercial Officer of Biomarin Pharmaceutical Inc (NASDAQ:BMRN), sold 5,000 shares of the company.